Table of Contents Author Guidelines Submit a Manuscript
Volume 2012 (2012), Article ID 923289, 10 pages
Review Article

Lipoprotein(a): Cellular Effects and Molecular Mechanisms

Division of Cardiovascular Medicine, Leeds Institute of Genetics, Health and Therapeutics (LIGHT) and Multidisciplinary Cardiovascular Research Centre (MCRC), University of Leeds, Leeds LS2 9JT, UK

Received 11 June 2012; Accepted 24 July 2012

Academic Editor: Michael Ibrahim

Copyright © 2012 Kirsten Riches and Karen E. Porter. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [15 citations]

The following is the list of published articles that have cited the current article.

  • Kirsten Riches, Larissa Franklin, Azhar Maqbool, Michelle Peckham, Matthew Adams, Jacquelyn Bond, Philip Warburton, Nicole T. Feric, Marlys L. Koschinsky, David J. O’Regan, Stephen G. Ball, Neil A. Turner, and Karen E. Porter, “Apolipoprotein(a) acts as a chemorepellent to human vascular smooth muscle cells via integrin αVβ3 and RhoA/ROCK-mediated mechanisms,” The International Journal of Biochemistry & Cell Biology, 2013. View at Publisher · View at Google Scholar
  • Valmore Bermúdez, Joselyn Rojas, Juan Salazar, Luis Bello, Roberto Áñez, Alexandra Toledo, Maricarmen Chacín, Miguel Aguirre, Marjorie Villalobos, Mervin Chávez, María Sofía Martínez, Wheeler Torres, Yaquelin Torres, José Mejías, Edgardo Mengual, Liliana Rojas, Milagro Sánchez de Rosales, Ana Quevedo, Raquel Cano, Mayela Cabrera, Rafael París, Adonías Lubo, María Montiel, and Climaco Cano, “Variations of Lipoprotein(a) Levels in the Metabolic Syndrome: A Report from the Maracaibo City Metabolic Syndrome Prevalence Study,” Journal of Diabetes Research, vol. 2013, pp. 1–12, 2013. View at Publisher · View at Google Scholar
  • Michele Malaguarnera, Marco Vacante, Cristina Russo, Giulia Malaguarnera, Tijana Antic, Lucia Malaguarnera, Rita Bella, Giovanni Pennisi, Fabio Galvano, and Alessandro Frigiola, “Lipoprotein(a) in Cardiovascular Diseases,” BioMed Research International, vol. 2013, pp. 1–9, 2013. View at Publisher · View at Google Scholar
  • Berta Esteban-Fernandez de Avila, Susana Campuzano, Maria Pedrero, J-Pablo Salvador, M-Pilar Marco, and Jose M. Pingarron, “Lipoprotein(a) determination in human serum using a nitrilotriacetic acid derivative immunosensing scaffold on disposable electrodes,” Analytical and Bioanalytical Chemistry, vol. 406, no. 22, pp. 5379–5387, 2014. View at Publisher · View at Google Scholar
  • Rene Weiss, Andreas Spittler, Gerd Schmitz, Michael B. Fischer, and Viktoria Weber, “Thrombocyte Adhesion and Release of Extracellular Microvesicles Correlate with Surface Morphology of Adsorbent Polymers for Lipid Apheresis,” Biomacromolecules, vol. 15, no. 7, pp. 2648–2655, 2014. View at Publisher · View at Google Scholar
  • Raul Cavalcante Maranhao, Priscila Oliveira Carvalho, Celia Cassaro Strunz, and Fulvio Pileggi, “Lipoprotein (a): Structure, Pathophysiology and Clinical Implications,” Arquivos Brasileiros de Cardiologia, vol. 103, no. 1, pp. 76–83, 2014. View at Publisher · View at Google Scholar
  • P.R. Criado, D.P.S. Espinell, P. Barreto, T.H.B. Di Giacomo, and M.N. Sotto, “Lipoprotein(a) and livedoid vasculopathy: A new thrombophilic factor?,” Medical Hypotheses, 2015. View at Publisher · View at Google Scholar
  • Amirhosssein Sahebkar, Željko Reiner, Luis E. Simental-Mendía, Gianna Ferretti, and Arrigo F.G. Cicero, “Effect of extended-release niacin on plasma Lipoprotein(a) levels: a systematic review and meta-analysis of randomized placebo-controlled trials,” Metabolism, 2016. View at Publisher · View at Google Scholar
  • M. Bucci, C. Tana, M.A. Giamberardino, and F. Cipollone, “Lp(a) and cardiovascular risk: Investigating the hidden side of the moon,” Nutrition, Metabolism and Cardiovascular Diseases, 2016. View at Publisher · View at Google Scholar
  • E. A. Klesareva, O. I. Afanas’eva, V. V. Donskikh, I. Yu. Adamova, and S. N. Pokrovskii, “Characteristics of Lipoprotein(a)-Containing Circulating Immune Complexes as Markers of Coronary Heart Disease,” Bulletin of Experimental Biology and Medicine, 2016. View at Publisher · View at Google Scholar
  • M. Florentin, M. S. Elisaf, C. V. Rizos, V. Nikolaou, E. Bilianou, C. Pitsavos, and E. N. Liberopoulos, “l-Carnitine/Simvastatin Reduces Lipoprotein (a) Levels Compared with Simvastatin Monotherapy: A Randomized Double-Blind Placebo-Controlled Study,” Lipids, 2016. View at Publisher · View at Google Scholar
  • Yoshiki Shimatsu, Wataru Horii, Tetsuo Nunoya, Akira Iwata, Jianglin Fan, and Masayuki Ozawa, “Production of human apolipoprotein(a) transgenic NIBS miniature pigs by somatic cell nuclear transfer,” Experimental Animals, vol. 65, no. 1, pp. 37–43, 2016. View at Publisher · View at Google Scholar
  • Anja Vogt, “Lipoprotein(a)-apheresis in the light of new drug developments,” Atherosclerosis Supplements, 2017. View at Publisher · View at Google Scholar
  • Gianna Ferretti, Tiziana Bacchetti, Luis E. Simental-Mendía, Željko Reiner, Maciej Banach, and Amirhossein Sahebkar, “Raloxifene Lowers Plasma Lipoprotein(a) Concentrations: a Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials,” Cardiovascular Drugs and Therapy, 2017. View at Publisher · View at Google Scholar
  • Thomas G. Liman, Matthias Endres, Kristin S. Lange, Alexander H. Nave, Ulrike Grittner, and Martin Ebinger, “Lipoprotein(a) levels and recurrent vascular events after first ischemic stroke,” Stroke, vol. 48, no. 1, pp. 36–42, 2017. View at Publisher · View at Google Scholar